161 related articles for article (PubMed ID: 21526898)
1. The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.
Ikotun OF; Lapi SE
Future Med Chem; 2011 Apr; 3(5):599-621. PubMed ID: 21526898
[TBL] [Abstract][Full Text] [Related]
2. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Chem Rev; 2010 May; 110(5):2858-902. PubMed ID: 20415480
[No Abstract] [Full Text] [Related]
3. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
Miller PW; Long NJ; Vilar R; Gee AD
Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceutical chemistry for positron emission tomography.
Li Z; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional positron emission tomography imaging with 124I and 86Y.
Vandenberghe S
Nucl Med Commun; 2006 Mar; 27(3):237-45. PubMed ID: 16479243
[TBL] [Abstract][Full Text] [Related]
6. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
7. Challenges and opportunities for positron-emission tomography in personalized medicine.
Smith SV
IDrugs; 2005 Oct; 8(10):827-33. PubMed ID: 16254803
[TBL] [Abstract][Full Text] [Related]
8. Review on production of 89Zr in a medical cyclotron for PET radiopharmaceuticals.
Kasbollah A; Eu P; Cowell S; Deb P
J Nucl Med Technol; 2013 Mar; 41(1):35-41. PubMed ID: 23327781
[TBL] [Abstract][Full Text] [Related]
9. Developing new molecular imaging probes for PET.
Serdons K; Verbruggen A; Bormans GM
Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
[TBL] [Abstract][Full Text] [Related]
10. [Positron emission tomography: basic principle and radionuclides/probes for metabolic/functional analysis].
Saga T; Yoshikawa K; Ishizu K
Rinsho Byori; 2007 Jul; 55(7):630-8. PubMed ID: 17718059
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
Ruangma A; Bai B; Lewis JS; Sun X; Welch MJ; Leahy R; Laforest R
Nucl Med Biol; 2006 Feb; 33(2):217-26. PubMed ID: 16546676
[TBL] [Abstract][Full Text] [Related]
12. PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.
Herzog H; Tellmann L; Scholten B; Coenen HH; Qaim SM
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):159-65. PubMed ID: 18043538
[TBL] [Abstract][Full Text] [Related]
13. [PET radiopharmaceuticals: novelties and new possibilities].
Környei J; Mikecz P; Tóth G
Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
[TBL] [Abstract][Full Text] [Related]
14. Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.
Hohn A; Zimmermann K; Schaub E; Hirzel W; Schubiger PA; Schibli R
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):145-50. PubMed ID: 18174878
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen M; Fettig NM; Rossin R
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography: physics, instrumentation, and image analysis.
Porenta G
Wien Klin Wochenschr; 1994; 106(15):466-77. PubMed ID: 7941595
[TBL] [Abstract][Full Text] [Related]
17. Orthogonal 18F and 64Cu labelling of functionalised bis(thiosemicarbazonato) complexes.
Carroll L; Bejot R; Hueting R; King R; Bonnitcha P; Bayly S; Christlieb M; Dilworth JR; Gee AD; Declerck J; Gouverneur V
Chem Commun (Camb); 2010 Jun; 46(23):4052-4. PubMed ID: 20407674
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
[TBL] [Abstract][Full Text] [Related]
19. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
20. Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects.
Pandey MK; DeGrado TR
Curr Radiopharm; 2021; 14(4):325-339. PubMed ID: 32867656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
